MedTech News
Biodegradable self-healing hydrogel combined with acupuncture shows promise for Parkinson’s disease
Researchers at National Taiwan University developed a biodegradable, electroconductive self-healing hydrogel combined with acupuncture that restores motor function and protects brain neurons in Parkinson’s disease models.
AI reveals how protein modifications link mutations to disease
Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations to disease. The method, called DeepMVP and published in Nature Methods, significantly outperforms previously published models and has implications for the development of novel therapeutics.
Light therapy provides new hope for Alzheimer’s patients
Researchers have developed a new light technology that appears to improve cognitive function in Alzheimer’s patients in clinical trials. The hope is that the idea can be developed into ordinary lamps that people can install to prevent the disease.
mRNA vaccine power enhanced for cancer and autoimmune disease prevention
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.
Early signs of Alzheimer’s could soon be spotted through routine eye exams
Within the next few years, doctors may be able to spot signs of Alzheimer’s disease and other dementias using routine eye exams well before symptoms appear, a new study suggests.
FDA grants breakthrough device designation for Quest Diagnostics’ MRD test
The liquid biopsy test has been developed by experts in cancer genomics.
Brightonix wins FDA nod for flagship PET imaging system
Brightonix Imaging announced today that its flagship Pharos positron emission tomography (PET) scanner received FDA clearance.
Abbott’s Esprit BTK System gains CE mark for PAD treatment
The stent is engineered to keep arteries open, deliver everolimus for vessel healing, and gradually dissolve over time.